Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Diagnostic Microbiology and Infectious Disease|September 30, 2018
Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and EuropeDavid B Huang, Sophie Magnet, Stefania De Angelis, et al.Infectious Diseases (London, England)|January 14, 2016
The changing epidemiology of group B streptococcus bloodstream infection: a multi-national population-based assessmentMark S Ballard, Henrik C Schønheyder, Jenny Dahl Knudsen, et al.International Journal of Antimicrobial Agents|April 14, 2015
Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: a 2014 follow-up surveyMatthew Dryden, Arjana Tambic Andrasevic, Matteo Bassetti, et al.International Journal of Antimicrobial Agents|May 22, 2018
Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infectionsDavid B Huang, G Ralph Corey, Thomas L Holland, et al.Zoonoses and Public Health|March 12, 2020
Study of general practitioner consultations for tick bites at high, medium and low incidence areas for Lyme borreliosis in England and WalesEmma L Gillingham, Jessica L Hall, Richard J Birtles, et al.Journal of Medical Microbiology|March 21, 2020
A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infectionsStephanie Noviello, G Ralph Corey, Thomas L Holland, et al.International Journal of Antimicrobial Agents|May 25, 2016
Hot topics in the diagnosis and management of skin and soft-tissue infectionsSilvano Esposito, Matteo Bassetti, Eric Bonnet, et al.Journal of Infection Prevention|March 20, 2018
<i>Clostridium difficile</i> multidisciplinary team root cause analysis: impact on clinical care and circumvention of financial penalties posed by clinical commissioning groups, but at what cost?Kordo Saeed, Christina Petridou, Hazel Gray, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2017
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1David B Huang, William O'Riordan, J Scott Overcash, et al.The Journal of Antimicrobial Chemotherapy|September 19, 2024
The United Nations' General Assembly High-Level Meeting on antimicrobial resistance: a joint statement from the Heads of Government and Chief Medical Officers of the United Kingdom's Overseas TerritoriesMatthew Dryden, Michael Corley, Natalie Wright, et al.Pageof 6